Canada Next Generation Cancer Diagnostics Market Size & Outlook

The next generation cancer diagnostics market in Canada is expected to reach a projected revenue of US$ 2,791.5 million by 2030. A compound annual growth rate of 8.9% is expected of Canada next generation cancer diagnostics market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,538.9
Forecast, 2030 (US$M)
$2,791.5
CAGR, 2024 - 2030
8.9%
Report Coverage
Canada

Canada next generation cancer diagnostics market highlights

  • The Canada next generation cancer diagnostics market generated a revenue of USD 1,538.9 million in 2023 and is expected to reach USD 2,791.5 million by 2030.
  • The Canada market is expected to grow at a CAGR of 8.9% from 2024 to 2030.
  • In terms of segment, next generation sequencing was the largest revenue generating technology in 2023.
  • Next Generation Sequencing is the most lucrative technology segment registering the fastest growth during the forecast period.


Next generation cancer diagnostics market data book summary

Market revenue in 2023USD 1,538.9 million
Market revenue in 2030USD 2,791.5 million
Growth rate8.9% (CAGR from 2023 to 2030)
Largest segmentNext generation sequencing
Fastest growing segmentNext Generation Sequencing
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationNext Generation Sequencing, QPCR & Multiplexing, LOAC & RT-PCR, Protein Microarrays, DNA Microarrays
Key market players worldwideJohnson & Johnson, Illumina Inc, Novartis AG ADR, Roche, Koninklijke Philips NV, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, GE HealthCare Technologies Inc Common Stock


Other key industry trends

  • In terms of revenue, Canada accounted for 9.8% of the global next generation cancer diagnostics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. next generation cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 2,791.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Next Generation Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website

Canada next generation cancer diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next generation cancer diagnostics market will help companies and investors design strategic landscapes.


Next generation sequencing was the largest segment with a revenue share of 36.95% in 2023. Horizon Databook has segmented the Canada next generation cancer diagnostics market based on next generation sequencing, qpcr & multiplexing, loac & rt-pcr, protein microarrays, dna microarrays covering the revenue growth of each sub-segment from 2018 to 2030.


Presence of cancer care centers such as Cancer Care Ontario, Prostate Cancer Canada, and Atlantic Cancer Research Institute that are involved in development of companion diagnostics and personalized medicine are anticipated to impact regional growth through to 2024.

According to data published by the Canadian Cancer Statistics, it has been estimated that burden of cancer on Canadian population in 2014 was 191,300 and the mortality was about 76,600.

Research carried out by the market entities in order to curb these rising rates of cancer incidence is estimated to provide this region with a number of lucrative avenues for growth over the forecast period.

Reasons to subscribe to Canada next generation cancer diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada next generation cancer diagnostics market databook

  • Our clientele includes a mix of next generation cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada next generation cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada next generation cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada next generation cancer diagnostics market size, by technology, 2018-2030 (US$M)

Canada Next Generation Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)

Canada next generation cancer diagnostics market size, by technology, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more